Justin Stebbing shared a post by Biorasi, on LinkedIn:

“had a nice chat with Chris O’Brien…”

Quoting Biorasi‘s post:

“‘The great thing about science is that it’s very humbling. You learn every day from the patients, from the diseases, but also from the research.’ – Justin Stebbing, Editor-in-Chief of Oncogene, previously the UK’s first NIHR (National Institute for Health and Care Research) Research Translational Professor of Oncology, Professor of Biomedical Sciences, Anglia Ruskin University, Cambridge.

Tune in tomorrow for a new episode of the Few and Far Between podcast. Host Chris O’Brien welcomes Professor Justin Stebbing to the podcast for a conversation on improving the quality and quantity of life for every patient, one step at a time.”

Source: Justin Stebbing/LinkedIn and Biorasi/LinkedIn

Justin Stebbing is a visiting Professor of Cancer Medicine and Oncology at Imperial College, London and a Professor of Biomedical Sciences at Anglia Ruskin University (ARU), Cambridge. He was appointed the first NIHR oncology professor in 2011. He is editor-in-chief of Nature’s cancer journal Oncogene. Prof. Stebbing has published over 700 peer-reviewed papers in leading academic journals. He is a member of the American Society for Clinical Investigation, a fellow of the Royal College of Physicians, and the Royal College of Pathologists, and sits on many advisory boards. He is on the Editorial Board of OncoDaily.